Skip to content


When we think about what causes our skin to look different over time, we often point to the usual suspects: sun exposure, genetics, or just the ticking clock. However, there's a less visible but equally significant factor at play—chronic inflammation. This silent assassin not only affects our health but also has a profound impact on our skin's appearance, particularly when it comes to collagen, the protein that keeps our skin looking firm and healthy.

Chronic Inflammation: The Invisible Enemy of Healthy Skin

Chronic inflammation is like a low-grade fire that burns continuously within the body, including the skin. It can stem from various sources—stress, pollution, poor diet, or skin conditions like dermatitis. Unlike acute inflammation, which is the body's healthy response to injury or infection, chronic inflammation can subtly degrade the skin's structure, particularly collagen.

How Inflammation Alters Skin's Foundation

Collagen is the scaffolding of our skin, providing it with strength and elasticity. But when chronic inflammation is in the picture, this scaffolding undergoes harmful changes:

  • Shift in Collagen Composition: The balance tips, increasing type III collagen, which is weaker compared to the sturdier type I collagen predominant in healthy skin. Imagine your skin switching out some of its strong, sturdy building blocks for weaker ones in the foundation of your "house." That's what happened when the balance of collagen types gets thrown off by inflammation. 
  • Collagen Becomes Rigid: The denaturation temperature of collagen rises, meaning it's less flexible and more likely to stay in a damaged form. It becomes tougher and doesn't breakdown as easily. This might sound good, but it means that your skin can't renew itself properly, leading to older, damaged collagen hanging around too long.
  • Over-Hydroxylation: This fancy term means that inflammation makes collagen too dense and stiff by adding too many hydroxyl groups to its structure, affecting how it interacts with the cells around it and its overall stability. This process that is usually highly fine-tuned, goes into overdrive, making it behave differently ....not in a good way.
  • Stubborn Against Breakdown: Normally, certain enzymes help clear out old or damaged collagen, making room for fresh, healthy collagen. But inflamed skin's collagen resists this process, sticking around when it's not welcome. This makes it hard for the skin to renew and repair itself.

Got Collagen? - Dermatology Care of Charlotte

Why This Matters More Than You Think

You might wonder why these microscopic changes to collagen should matter to you. Here's the deal: they directly impact how your skin heals, ages, and responds to treatments.

  • Slow Healing: With its structure compromised, collagen can't properly support the skin's healing process. Small damages accrue over time, leading to visible signs of aging and reduced skin health.
  • Treatments Might Not "Take" As Well: Thinking about getting fillers or undergoing scar revision? Inflamed skin might not hold onto or respond these enhancements as it should, leading to disappointing results. It's like trying to build on a shaky foundation. Lets be real, things like acne should be under control before you step foot into the scar revision game fam...
  • Inflammation Must Be Tackled First: Before you even consider stepping into a dermatologist's office for cosmetic procedures, it's crucial to get inflammation under control. This ensures that your skin is in the best state possible for any treatment and can fully benefit from it.

Crafting a Skin Care Plan That Works

Knowing the impact of chronic inflammation on skin health, especially collagen, it's important to understand that a multi-system approach is necessary to not just improve the appearance of your skin, but to ensure its deep, dermal health.

  • Extinguish the Inflammation: This might involve changes in your diet to avoid inflammatory foods, integrating stress-reduction techniques into your daily routine, medication, or using skincare products specifically formulated to soothe inflammation.
  • Boost Collagen the Right Way: Look for products and treatments that genuinely support collagen repair and synthesis. Ingredients like vitamin C, retinoids, and peptides can be your allies. I'm a huge fan of these ingredients for scar revision!
  • Timing Is Everything: If you're considering cosmetic treatments, ensure your skin's inflammatory issues are addressed beforehand. So manage your expectations, this may take a few months, even upward to a year. This will make any procedure more effective, you're not wasting money and ensure your investments in your skin are in it for the long haul.

iS Clinical Super Serum Advance+ | VIOLET GREY

iS CLINICAL Super Serum Advanced Serum I love for scar revision, age management, maintenance and luminosity.

The journey to understanding and combating the effects of chronic inflammation on collagen and by extension, your skin's health and key. It's not just about battling visible signs of aging but ensuring your skin remains vibrant, resilient, and healthy from the inside out. By focusing on reducing inflammation first, you're setting the stage for a skin that not only looks better but truly is healthier, able to stand up to the challenges of time and the environment with grace.

Questions? Comments?

acne, inflammation, collagen, scar revision


  • AKUTSU, N., NISHIYAMA, T., HORII, I., & HAYASHI, T. (2000). Repression of fibroblast migration into the collagen gel incubated with glucose is due to glycation-mediated cross-linking of collagen. Connective tissue, 32(3), 267-272.
  • Bailey, A. J., Bazin, S. T., & Delaunay, A. (1973). Changes in the nature of the collagen during development and resorption of granulation tissue. Biochimica et Biophysica Acta (BBA)-Protein Structure, 328(2), 383-390.
  • Brinckmann, J., Tronnier, M., Schmeller, W., Notbohm, H., Açil, Y., Fietzek, P. P., ... & Bätge, B. (1999). Overhydroxylation of lysyl residues is the initial step for altered collagen cross-links and fibril architecture in fibrotic skin. Journal of investigative dermatology, 113(4), 617-621.
  • Burjanadze, T. V. (1979). Hydroxyproline content and location in relation to collagen thermal stability. Biopolymers: Original Research on Biomolecules, 18(4), 931-938.
  • Butler, W. T., & Cunningham, L. W. (1966). Evidence for the linkage of a disaccharide to hydroxylysine in tropocollagen. Journal of Biological Chemistry, 241(17), 3882-3888.
  • Byers, P. H., McKenney, K. H., Lichtenstein, J. R., & Martin, G. R. (1974). Preparation of type III procollagen and collagen from rat skin. Biochemistry, 13(25), 5243-5248.
  • ChandraRajan, J. (1978). Separation of type III collagen from type I collagen and pepsin by differential denaturation and renaturation. Biochemical and Biophysical Research Communications, 83(1), 180-186.
  • Docherty, A. J., & Murphy, G. (1990). The tissue metalloproteinase family and the inhibitor TIMP: a study using cDNAs and recombinant proteins. Annals of the rheumatic diseases, 49, 469-479.
  • Ebihara, T. (1999). Changes in the extractability of bovine skin collagen through the course of aging and biochemical properties of the collagen extracted. Connect. Tissue, 31, 17-23.
  • Fullana, F., Grande, L., Fernadez-Llamazares, J., Gonzalez-Mestre, V., & Salvá, J. A. (1993). Skin prolylhydroxylase activity and wound healing. European surgical research, 25(6), 370-375.
  • Grant, M. E., & Jackson, D. S. (1968). Carbohydrate content of bovine collagen preparations. Biochemical Journal, 108(4), 587-591.
  • Hayashi, T., & Nagai, Y. (1979). Separation of the α chains of type I and III collagens by SDS-polyacrylamide gel electrophoresis. The Journal of Biochemistry, 86(2), 453-459.
  • Itoh, T., Tanioka, M., Yoshida, H., Yoshioka, T., Nishimoto, H., & Itohara, S. (1998). Reduced angiogenesis and tumor progression in gelatinase A-deficient mice. Cancer research, 58(5), 1048-1051.
  • Kawano, E., Takahashi, S. I., Sakano, Y., & Fujimoto, D. (1990). Nonenzymatic glycation alters properties of collagen as a substratum for cells. Matrix, 10(5), 300-305.
  • Kobayashi, K., Ito, T., & Hoshino, T. (1985). Electron microscopic demonstration of acid-labile, 4D-staggered intermolecular association of collagen formed in vitro. Collagen and Related Research, 5(3), 253-260.
  • Kucharz, E. J. (2012). The collagens: biochemistry and pathophysiology. Springer Science & Business Media.
  • Kusubata, M., Hirota, A., Ebihara, T., Kuwaba, K., Matsubara, Y., Sasaki, T., ... & Koyama, Y. I. (1999). Spatiotemporal changes of fibronectin, tenascin-C, fibulin-1, and fibulin-2 in the skin during the development of chronic contact dermatitis. Journal of investigative dermatology, 113(6), 906-912.
  • Matrisian, L. M. (1990). Metalloproteinases and their inhibitors in matrix remodeling. Trends in Genetics, 6, 121-125.
  • Nagai, H. (1984). A micro-assay method of collagenase activity and its application in the study of collagen metabolism in pathological tissues. Part I Assay of collagenase activity using FITC-labeled collagen as substrate. Jpn. J. Inflammation, 4, 123-130.
  • Nishikawa, A., Taira, T., & Yoshizato, K. (1987). In vitro maturation of collagen fibrils modulates spreading, DNA synthesis, and collagenolysis of epidermal cells and fibroblasts. Experimental cell research, 171(1), 164-177.
  • Ohshima, M., Jung, S. K., Yasuda, T., Sakano, Y., & Fujimoto, D. (1993). Active oxygen-induced modification alters properties of collagen as a substratum for fibroblasts. Matrix, 13(3), 187-194.
  • O'Reilly, M. S., Boehm, T., Shing, Y., Fukai, N., Vasios, G., Lane, W. S., ... & Folkman, J. (1997). Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. cell, 88(2), 277-285.
  • Rao, C. N., Ladin, D. A., Chilukuri, K., Woodley, D. T., Liu, Y. Y., & Hou, Z. Z. (1995). α1-antitrypsin is degraded and non-functional in chronic wounds but intact and functional in acute wounds: the inhibitor protects fibronectin from degradation by chronic wound fluid enzymes. Journal of investigative dermatology, 105(4), 572-578.
  • Ricard-Blum, S., Esterre, P., & Grimaud, J. A. (1993). Collagen cross-linking by pyridinoline occurs in non-reversible skin fibrosis. Cellular and molecular biology (Noisy-le-Grand, France), 39(7), 723-727.
  • Sato, K., EBIHARA, T., ADACHI, E., KAWASHIMA, S., HATTORI, S., & IRIE, S. (2000). The reconstituted type I collagen fibrils from skins of variously aged bovines exert different effects on the morphology and integrin α2β1 expression of fibroblasts in culture. Connective tissue, 32(1), 1-10.
  • Spiro, R. G. (1969). Characterization and quantitative determination of the hydroxylysine-linked carbohydrate units of several collagens. Journal of Biological Chemistry, 244(3), 602-612.
  • Torre-Blanco, A., Adachi, E., Hojima, Y., Wootton, J. A., Minor, R. R., & Prockop, D. J. (1992). Temperature-induced post-translational over-modification of type I procollagen. Effects of over-modification of the protein on the rate of cleavage by procollagen N-proteinase and on self-assembly of collagen into fibrils. Journal of Biological Chemistry, 267(4), 2650-2655
  • Turck, J., Pollock, A. S., Lee, L. K., Marti, H. P., & Lovett, D. H. (1996). Matrix metalloproteinase 2 (gelatinase A) regulates glomerular mesangial cell proliferation and differentiation. Journal of Biological Chemistry, 271(25), 15074-15083.
  • Vaalamo, M., Mattila, L., Johansson, N., Kariniemi, A. L., Karjalainen-Lindsberg, M. L., Kähäri, V. M., & Saarialho-Kere, U. (1997). Distinct populations of stromal cells express collagenase-3 (MMP-13) and collagenase-1 (MMP-1) in chronic ulcers but not in normally healing wounds. Journal of Investigative Dermatology, 109(1), 96-101.
  • Woessner Jr, J. F. (1991). Matrix metalloproteinases and their inhibitors in connective tissue remodeling. The FASEB Journal, 5(8), 2145-2154.

Leave a reply

Your email address will not be published..

Quick Shop